...
首页> 外文期刊>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics >Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
【24h】

Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.

机译:评估唾液腺肿瘤,腺样囊性癌,多态性低度腺癌,基底细胞和小管腺瘤中p63的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The purpose of this study was to determine the extent of p63 immunoreactivity in the malignant salivary gland neoplasms adenoid cystic carcinoma (ACC) and polymorphous low-grade adenocarcinoma (PLGA) and to compare this to the expression of this marker in the benign salivary gland tumors canalicular adenoma and basal cell adenoma. Few studies on the expression of p63 in head and neck salivary gland tumors have been published to date. P63, a selective immunohistochemical marker of basal/stem cells of stratified epithelium and of myoepithelial cells, is a p53 homologue that plays an essential role in both morphogenesis of epidermis and limb development. P63 immunoreactivity has been demonstrated in squamous cell and urothelial carcinomas. It is generally absent in most nonsquamous cell carcinomas.Study design Formalin-fixed paraffin-embedded sections from 49 salivary gland neoplasms, representing 6 canalicular adenomas, 11 basal cell adenomas, 17 PLGA and 15 ACC accessioned from 1989 to 2002 by the Department of Pathology, Long Island Jewish Medical Center, New Hyde Park, NY, were stained with an anti-p63 monoclonal antibody. RESULTS: Nuclear p63 reactivity was uniformly positive in PLGA (17/17, 100%). Positive reactivity was also identified in the majority of cases of ACC (13/15, 87%), primarily in the nonluminal myoepithelial-like cells surrounding luminal cells. Canalicular adenoma did not exhibit any p63 immunoreactivity. All basal cell adenomas of parotid origin stained strongly for p63, with staining localized to the peripheral tumor cells situated adjacent to the connective tissue stroma. None of the basal cell adenomas originating in the upper lip stained with p63. In native adjacent salivary gland tissue, p63 reactivity was identified focally in the nuclei of myoepithelial and basal duct cells. CONCLUSIONS: P63 is strongly expressed in basal cell adenoma of parotid origin, and in ACC and PLGA. Canalicular adenoma did not demonstrate p63 staining, consistent with this tumor's putative luminal ductal cell differentiation. Our results suggest that the neoplastic cells in PLGA may represent either a population of p63-positive epithelial stem/reserve cells similar to the basal cells of stratified epithelium, or modified myoepithelial cells. Given the staining pattern of the tumors examined, p63 does not appear to be an ideal marker for distinguishing between ACC, PLGA, and basal cell adenoma.
机译:目的:本研究的目的是确定恶性涎腺肿瘤,腺样囊性癌(ACC)和多形性低度腺癌(PLGA)中p63免疫反应的程度,并将其与该标志物在良性唾液中的表达进行比较腺体肿瘤小管腺瘤和基底细胞腺瘤。迄今为止,关于头颈部唾液腺肿瘤中p63表达的研究很少。 P63是分层上皮的基础/干细胞和肌上皮细胞的选择性免疫组织化学标记,是p53同源物,在表皮的形态发生和肢体发育中都起着重要作用。 P63免疫反应性已在鳞状细胞癌和尿路上皮癌中得到证实。研究设计从49例唾液腺肿瘤中福尔马林固定石蜡包埋的切片中进行研究设计,这些切片代表6例小管腺瘤,11例基底细胞腺瘤,17例PLGA和15例ACC。位于纽约州新海德公园市长岛犹太医学中心的抗p63单克隆抗体被染色。结果:PLGA中的核p63反应性始终为阳性(17 / 17,100%)。在大多数ACC病例(13 / 15,87%)中,主要在管腔细胞周围的非管腔肌上皮样细胞中,也发现了阳性反应性。小管腺瘤没有任何p63免疫反应性。腮腺来源的所有基底细胞腺瘤均被p63强烈染色,染色局限于与结缔组织基质相邻的周围肿瘤细胞。没有一个起源于上唇的基底细胞腺瘤被p63染色。在邻近的天然唾液腺组织中,在肌上皮和基底管细胞的细胞核中发现了p63反应性。结论:P63在腮腺起源的基底细胞腺瘤以及ACC和PLGA中强烈表达。小管腺瘤未显示p63染色,与该肿瘤的假定管腔导管细胞分化一致。我们的结果表明,PLGA中的赘生性细胞可能代表与分层上皮基底细胞相似的p63阳性上皮干/储备细胞群,或修饰的肌上皮细胞。考虑到所检查肿瘤的染色模式,p63似乎不是区分ACC,PLGA和基底细胞腺瘤的理想标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号